$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Express delivery! Novartis c-Met inhibitor "capmatinib" applies for marketing in China
2025-10-19 11:44:20
Check Details
The efficacy of nivolumab in treating gastric cancer: is it an immune drug or a targeted drug?
2025-10-19 11:44:20
Check Details
What is the effect of nivolumab combined with chemotherapy? What drug should be used with chemotherapy?
2025-10-19 11:44:20
Check Details
Is gefitinib a targeted drug and is it effective?
2025-10-19 11:44:20
Check Details
What are the indications and pharmacological effects of erlotinib?
2025-10-19 11:44:20
Check Details
Is afatinib effective and how to take it?
2025-10-19 11:44:20
Check Details
Is it necessary to take afatinib for early stage lung cancer? What are the adverse reactions?
2025-10-19 11:44:20
Check Details
Afatinib is a targeted drug of several generations. What diseases does it mainly treat?
2025-10-19 11:44:20
Check Details
What diseases does Osimertinib treat and is it effective?
2025-10-19 11:44:20
Check Details
Is Dacomitinib effective? How much does it cost per bottle?
2025-10-19 11:44:20
Check Details
What is the difference between osimertinib and dacomitinib, which drug is more effective?
2025-10-19 11:44:20
Check Details
What causes diarrhea while taking dacomitinib and how to deal with it?
2025-10-19 11:44:20
Check Details
1
2
...
4113
4114
4115
4116
4117
4118
4119
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Garsorasib Clinical Updates and KRAS G12C Targeted Therapy Prospects
2
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
3
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
4
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
5
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
12
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer